These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8937535)

  • 61. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
    Elger C; Halász P; Maia J; Almeida L; Soares-da-Silva P;
    Epilepsia; 2009 Mar; 50(3):454-63. PubMed ID: 19243424
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study.
    Biton V; Di Memmo J; Shukla R; Lee YY; Poverennova I; Demchenko V; Saiers J; Adams B; Hammer A; Vuong A; Messenheimer J
    Epilepsy Behav; 2010 Nov; 19(3):352-8. PubMed ID: 20937567
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, eleven-week study.
    Matsuo F; Gay P; Madsen J; Tolman KG; Rollins DE; Risner ME; Lai AA
    Epilepsia; 1996 Sep; 37(9):857-62. PubMed ID: 8814098
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures.
    Krauss GL; Serratosa JM; Villanueva V; Endziniene M; Hong Z; French J; Yang H; Squillacote D; Edwards HB; Zhu J; Laurenza A
    Neurology; 2012 May; 78(18):1408-15. PubMed ID: 22517103
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial.
    Zakrzewska JM; Chaudhry Z; Nurmikko TJ; Patton DW; Mullens LE
    Pain; 1997 Nov; 73(2):223-230. PubMed ID: 9415509
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
    Biton V; Gil-Nagel A; Isojarvi J; Doty P; Hebert D; Fountain NB
    Epilepsy Behav; 2015 Nov; 52(Pt A):119-27. PubMed ID: 26414341
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Lamotrigine: first experience in Italy].
    de Romanis F; Sopranzi N
    Clin Ter; 1995 Mar; 146(3):203-9. PubMed ID: 7789082
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.
    Ettinger AB; Kustra RP; Hammer AE
    Epilepsy Behav; 2007 Feb; 10(1):148-54. PubMed ID: 17071141
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Lamotrigine treatment of 92 patients with intractable epilepsy].
    Karlsborg M; Gram L; Dam M
    Ugeskr Laeger; 1996 Apr; 158(14):1969-72. PubMed ID: 8650771
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY; Jiang W; Lionberger R; Wong J; Jones JW; Kane MA; Krumholz A; Temple R; Polli JE
    Epilepsia; 2015 Sep; 56(9):1415-24. PubMed ID: 26201987
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lamotrigine in absence and primary generalized epilepsies.
    Mikati MA; Holmes GL
    J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The clinical efficacy of lamotrigine as an antiepileptic drug.
    Pellock JM
    Neurology; 1994 Nov; 44(11 Suppl 8):S29-35. PubMed ID: 7970004
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lamotrigine trial in idiopathic parkinsonism: a double-blind, placebo-controlled, crossover study.
    Shinotoh H; Vingerhoets FJ; Lee CS; Uitti RJ; Schulzer M; Calne DB; Tsui J
    Neurology; 1997 May; 48(5):1282-5. PubMed ID: 9153458
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Improved sexual function in three men taking lamotrigine for epilepsy.
    Husain AM; Carwile ST; Miller PP; Radtke RA
    South Med J; 2000 Mar; 93(3):335-6. PubMed ID: 10728528
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures.
    Faught E; Ayala R; Montouris GG; Leppik IE;
    Neurology; 2001 Nov; 57(10):1774-9. PubMed ID: 11723262
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Combined therapy with lamotrigine++ in primary generalized epilepsy in adult patients].
    Wender M; Pruchnik-Wolińska D
    Neurol Neurochir Pol; 1998; 32(1):23-9. PubMed ID: 9631375
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Delirium from valproic acid with lamotrigine.
    Mueller TH; Beeber AR
    Am J Psychiatry; 2004 Jun; 161(6):1128-9. PubMed ID: 15169707
    [No Abstract]   [Full Text] [Related]  

  • 78. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lamotrigine as an add-on drug in typical absence seizures.
    Ferrie CD; Robinson RO; Knott C; Panayiotopoulos CP
    Acta Neurol Scand; 1995 Mar; 91(3):200-2. PubMed ID: 7793236
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial.
    Privitera MD; Welty TE; Gidal BE; Diaz FJ; Krebill R; Szaflarski JP; Dworetzky BA; Pollard JR; Elder EJ; Jiang W; Jiang X; Berg M
    Lancet Neurol; 2016 Apr; 15(4):365-72. PubMed ID: 26875743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.